Arecor Therapeutics plc (LON:AREC – Get Free Report) was up 0.4% on Thursday . The company traded as high as GBX 74.30 ($0.96) and last traded at GBX 74.30 ($0.96). Approximately 3,000 shares changed hands during trading, a decline of 79% from the average daily volume of 14,507 shares. The stock had previously closed at GBX 74 ($0.96).
Arecor Therapeutics Stock Up 3.4 %
The firm has a 50 day moving average of GBX 75.33 and a 200 day moving average of GBX 106.42. The firm has a market cap of £29.08 million, a price-to-earnings ratio of -275.00 and a beta of -0.18. The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Recommended Stories
- Five stocks we like better than Arecor Therapeutics
- Insider Trades May Not Tell You What You Think
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What is a Stock Market Index and How Do You Use Them?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Roth IRA Calculator: Calculate Your Potential Returns
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
